Vertex Pharmaceuticals Inc
VRTX· Nasdaq
Released May 5, 2022, after the close
10-Q filed May 6, 2022, 36 days after period end · 0000875320-22-000014
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $2.10B | $1.72B | $1.52B | $858.44M |
| Net Income | $762.10M | $653.10M | $602.75M | $268.63M |
| EPS Diluted |
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR
| $2.96 |
| $2.49 |
| $2.29 |
| $1.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.